Stock Chart

MDT

$101.61 +0.02%
Score: 39.2 AVOID NEW MONEY
LEAPs: SELL $110
i
LEAPs Option Signal

Type: SELL growth_1yr
Strike: $110
Premium: $6.72
Expiry: Sep 17, 2027
Target: $106
Score: -100

LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol: 0.29x (vs SPY: 0.4x | vs QQQ: 0.4x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Nov 11, 2026
Bull Pennant weak / forming — below our quality gate quality 49/100
A Bull Pennant is taking shape but hasn't passed our quality gate (60/100), so no projected path or levels are shown — only the forming rails on the chart below.
Historically breaks up 70% of the time (n=1,684). Measured-move targets failed our backtest — none shown.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About MDT - Medtronic plc

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.

Key Statistics

Market Cap $130B
P/E Ratio 24.96
Dividend Yield 0.03%

This MDT stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track MDT's price movements with trendlines, gamma walls, and key support/resistance levels.